NexImmune priced shares at $17 to raise $110m in an upsized offering, enabling Amgen and Pfizer to exit the Johns Hopkins University spinout.

The vehicle charging technology developer, spun out of UC Irvine, has now raised $191m in total.

The gas-to-hydrogen technology developer bagged $11.5m in funding to commercialise technology developer at UC Santa Barbara.

We remember George Shultz, former University of Chicago Booth School of Business professor and dean.

A round up of the week's new fund and incbuator launches.

Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.

The past week's M&A exits included Genetirate, DataFleets and SightGlass Vision.

UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.

Osage University Partners has contributed to an oversubscribed series C round for Cyteir, which was led by RA Capital.

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.